Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793442 · ClinicalTrials.gov registry record
Endothelium in Severe Sepsis
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 910
- Enrollment target
NCT00793442: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT00793442 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 910 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00793442 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 910 participants
- Enrollment target
Study Summary
The overall hypotheses of this project is that severe sepsis is associated with endothelial dysfunction; that endothelial dysfunction, in turn, is predictive of subsequent organ failure and death; and that protocolized resuscitation attenuates endothelial cell (EC) dysfunction and improves patient survival.
Interventions
- DIAGNOSTIC_TEST Blood Collection and Assays
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 910 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-05 |
What the finished NCT00793442 record still lists
NCT00793442 is an observational study that tracks outcomes without assigning an intervention. The registered 910 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood Collection and Assays is the first listed.
NCT00793442 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00793442 about?
NCT00793442 is a clinical study titled "Endothelium in Severe Sepsis". The overall hypotheses of this project is that severe sepsis is associated with endothelial dysfunction; that endothelial dysfunction, in turn, is predictive of subsequent organ failure and death; and that protocolized resuscitation attenuates endothelial cell (EC) dysfunction and improves patient s...
What is the current status of trial NCT00793442?
This trial is currently completed. The enrollment target is 910 participants. The study started on 2008-03. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00793442?
The interventions under investigation include: Blood Collection and Assays (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00793442?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216548 · 909 participants · NA
E-PRIME For Children With Medical Complexity
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05739955 · 918 participants · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia